Australia Organ Preservation Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Australia Organ Preservation Market analysis

Part of: Organ Preservation Market (Global)

The Australia Organ Preservation Market was valued at $15.41 Million in 2025 and projected to reach to $21.24 Million by 2030, representing a compound annual growth rate of 6.6%. Australia's organ preservation market is positioned for consistent growth through 2030, driven by increasing transplantation demand and technological innovation.

Australia Organ Preservation Market Trends and Insights

This growth trajectory reflects Australia's advancing healthcare infrastructure and increasing demand for transplantation solutions.
Australia's market expansion is driven by rising organ donation awareness, improved preservation technologies, and enhanced clinical protocols across major transplant centers. The Australian organ preservation sector benefits from strong regulatory frameworks and government support for transplantation programs.
Australia's healthcare system prioritizes organ viability and patient outcomes, creating favorable conditions for preservation solution adoption.
Between 2025 and 2030, Australia is expected to see accelerated investment in cold storage systems, perfusion devices, and preservation media, supporting the projected 6.6% compound annual growth rate. Australia's position within the Asia Pacific region underscores the country's leadership in transplantation innovation and clinical excellence.
The market's growth reflects both domestic demand and Australia's role as a reference point for organ preservation best practices across the broader region..

Key Market Statistics

CAGR (2025-2030) 6.6% CAGR
Market Size, 2025 ~USD 15.41 Million
Forecast, 2030 ~USD 21.24 Million
Country Australia

Australia Organ Preservation Market Overview

Market Valuation :

Australia's organ preservation market is valued at USD 15.41 million in 2025, with a projected growth to USD 21.24 million by 2030, representing a steady CAGR of 6.6%.

Healthcare Infrastructure :

Australia's advanced healthcare system and robust transplantation network are driving adoption of sophisticated organ preservation technologies across major medical centers.

Donation Awareness :

Rising organ donation awareness campaigns and improved public engagement in Australia are increasing the volume of available organs, necessitating better preservation solutions.

Technology Advancement :

Australian hospitals are increasingly adopting innovative preservation technologies, including machine perfusion systems and advanced cold storage solutions, to improve transplant outcomes.

Australia Organ Preservation Market Dynamics

The country's strong healthcare infrastructure and commitment to improving transplant success rates support market expansion.
Rising awareness of organ donation and government initiatives promoting transplantation will further accelerate market growth.
Australian medical institutions are investing in advanced preservation technologies to enhance organ viability and reduce transplant failure rates, creating significant opportunities for market players..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
JOHNSON & JOHNSON

Key Takeaways

Australia's organ preservation market is valued at USD 15.41 million in 2025, with projected growth to USD 21.24 million by 2030.
Australia demonstrates a 6.6% CAGR, reflecting strong adoption of advanced preservation technologies and clinical best practices.
Australia's healthcare infrastructure and regulatory environment support sustained investment in organ preservation solutions.
Australia's market leadership in the Asia Pacific region positions the country as a key driver of transplantation innovation and clinical excellence.

Organ Preservation Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	PERFADEX (Solution)
Forecast Period	2025�2030
Growth Rate	CAGR of 6.8% from 2025 to 2030
Largest Segment	ORGAN TRANSPLANT CENTERS (End User)
Market Size Base Year (Billions)	~USD 0.22 (2025)
Revenue Forecast (Billions)	~USD 0.3 (2030)
Segments Covered	Solution, Technique, Organ Type, End User

Australia Organ Preservation Market Report Segmentation

4 segment dimensions are covered across the global market.

By Solution

Custodiol Htk
Other Solutions
Perfadex
University Of Wisconsin Solution

By Technique

Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Static Cold Storage

By Organ Type

Heart
Kidneys
Liver
Lungs
Other Organs

By End User

Hospitals
Organ Transplant Centers
Specialty Clinics

Target Audience

Medical Device Manufacturers : Manufacturers of organ preservation systems need Australia-specific market data to assess market size, growth potential, and competitive landscape for product launches and expansion strategies.
Healthcare Providers & Hospitals : Australian transplant centers and hospitals require market insights to evaluate preservation technology investments, benchmark against peers, and optimize transplant program outcomes.
Investment & Private Equity Firms : Investors targeting the Australian healthcare sector need detailed market analysis to identify growth opportunities, assess portfolio companies, and make informed funding decisions.
Government & Health Policy Bodies : Australian health authorities and policymakers use market data to develop transplantation strategies, allocate resources, and evaluate technology adoption across the healthcare system.
Pharmaceutical & Biotech Companies : Companies developing preservation solutions and supporting therapies need Australia-specific market intelligence to guide R&D investments and commercialization planning.

Key Companies in the Australia Organ Preservation Market

Company	HQ	Ownership	Strongest segments
KINDRED HEALTHCARE INC.	United States	Private Company	Static Cold Storage�linked care (all solutions),Hypothermic machine perfusion�linked care,Normothermic perfusion�linked care,
XVIVO PERFUSION AB	Sweden	Public Company	Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions,
TRANSMEDICS, INC.	United States	Public Company	OCS Heart,OCS Lung,OCS Liver,
BIOLIFE SOLUTIONS, INC.	United States	Public Company	HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport),
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.	China	Private Company	UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms),

KINDRED HEALTHCARE INC.

Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.

XVIVO PERFUSION AB

XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.

TRANSMEDICS, INC.

TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.

BIOLIFE SOLUTIONS, INC.

BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.

SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.

Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.

Reasons to Buy this Report

Market-Specific Sizing : Access precise valuation data for Australia's organ preservation market with verified 2025 baseline (USD 15.41M) and 2030 forecasts, enabling accurate business planning and investment decisions.
Growth Trajectory Analysis : Understand Australia's 6.6% CAGR performance relative to global 6.8% growth, identifying localized opportunities and competitive advantages within the Australian healthcare ecosystem.
Regulatory & Infrastructure Insights : Gain intelligence on Australia's healthcare infrastructure, transplantation networks, and regulatory environment specific to organ preservation technologies and market entry strategies.
Demand Driver Identification : Analyze Australia-specific factors including donation awareness trends, hospital adoption rates, and technology preferences to tailor product development and marketing strategies.
Competitive Positioning : Benchmark your organization against market dynamics in Australia, identify key stakeholders, and develop targeted go-to-market strategies for this high-growth healthcare segment.

Frequently asked questions

What is the current size of Australia's organ preservation market?

Australia's organ preservation market is valued at USD 15.41 million in 2025 and is expected to grow to USD 21.24 million by 2030.

What is the growth rate of Australia's organ preservation market?

Australia's organ preservation market is growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2030.

What factors are driving growth in Australia's organ preservation market?

Growth in Australia's organ preservation market is driven by rising organ donation awareness, improved preservation technologies, enhanced clinical protocols, and strong government support for transplantation programs.

Which preservation technologies are most relevant to Australia's market?

Australia's market focuses on cold storage systems, perfusion devices, and preservation media, all critical to maintaining organ viability for transplantation.

How does Australia's market compare to the broader Asia Pacific region?

Australia leads the Asia Pacific region in organ preservation innovation and clinical excellence, serving as a reference point for transplantation best practices across the broader region.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.

This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.

Primary Research

Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the organ preservation market includes the following details.

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach

Data Triangulation

The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.

Market Definition

Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.

Stakeholders

Association of Organ Procurement Organizations (AOPO)
American Transplant Congress (ATC)
United Network for Organ Sharing (UNOS)
Network & Alliance of Transplant Coordinators (NATCO)
Consortium for Organ Preservation in Europe (COPE)
European Society for Organ Transplantation (ESOT)
Asian Society of Transplantation (AST)
National Health Service (UK NHS)
International Registry on Organ Donation and Transplantation (IRODaT)
Global Observatory on Donation and Transplants (GODT)
National Institutes of Health (NIH)
World Health Organization (WHO)
Organisation for Economic Co-operation and Development (OECD)
Centers for Disease Control and Prevention (CDC)
Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
White Papers, Journals/Magazines, and News Articles

Report Objectives

To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering

Get the Full Organ Preservation Market Report

Full forecast, segment splits, and company analysis for all Organ Preservation Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies